Alzamend Neuro, Inc. (ALZN)

NASDAQ: ALZN · IEX Real-Time Price · USD
0.923
-0.014 (-1.54%)
At close: May 16, 2022 4:00 PM
0.910
-0.013 (-1.408%)
After-hours:May 16, 2022 7:59 PM EDT

Income Statement (Annual)

Millions USD. Fiscal year is May - Apr.
Year202020192018
Selling, General & Admin
3.643.351.31
Research & Development
1.311.073.7
Operating Expenses
4.954.425.01
Operating Income
-4.95-4.42-5.01
Interest Expense / Income
0.1600
Other Expense / Income
-0.06-0.01-0.15
Pretax Income
-5.05-4.41-4.86
Net Income
-5.05-4.41-4.86
Net Income Common
-5.05-4.41-4.86
Shares Outstanding (Basic)
737159
Shares Outstanding (Diluted)
737159
Shares Change
1.96%21.09%-
EPS (Basic)
-0.07-0.06-0.08
EPS (Diluted)
-0.07-0.06-0.08
Free Cash Flow Per Share
-0.04-0.03-0.02
EBITDA
-4.89-4.41-4.86
EBIT
-4.89-4.41-4.86
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).